ArticleJournal of thoracic disease2025

Two versus three to four cycles of neoadjuvant immunochemotherapy for stage IB-IIIB non-small cell lung cancer: a real-world study.

Yuhong Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.